CA2271770A1 - Procede de detection du cancer de la prostate metastatique - Google Patents
Procede de detection du cancer de la prostate metastatique Download PDFInfo
- Publication number
- CA2271770A1 CA2271770A1 CA002271770A CA2271770A CA2271770A1 CA 2271770 A1 CA2271770 A1 CA 2271770A1 CA 002271770 A CA002271770 A CA 002271770A CA 2271770 A CA2271770 A CA 2271770A CA 2271770 A1 CA2271770 A1 CA 2271770A1
- Authority
- CA
- Canada
- Prior art keywords
- dna
- oligonucleotide
- amount
- seq
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Abstract
Selon le procédé de la présente invention, on détecte le cancer de la prostate en déterminant la présence d'un polypeptide glandullaire spécifique de la prostate appelé Kallikrein (hK2) ou d'un ARN de hK2 dans un échantillon physiologique.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75935496A | 1996-11-14 | 1996-11-14 | |
US08/759,354 | 1996-11-14 | ||
PCT/US1997/020948 WO1998021365A2 (fr) | 1996-11-14 | 1997-11-14 | Procede de detection du cancer de la prostate metastatique |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2271770A1 true CA2271770A1 (fr) | 1998-05-22 |
Family
ID=25055346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002271770A Abandoned CA2271770A1 (fr) | 1996-11-14 | 1997-11-14 | Procede de detection du cancer de la prostate metastatique |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0941368A2 (fr) |
JP (1) | JP2001503991A (fr) |
CN (1) | CN1238013A (fr) |
AU (1) | AU737659B2 (fr) |
CA (1) | CA2271770A1 (fr) |
WO (1) | WO1998021365A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2360073C (fr) | 1999-01-28 | 2011-01-18 | Gen-Probe Incorporated | Sondes et amorces pour la detection d'antigene prostatique specifique (psa) dans un echantillon biologique |
FI990382A0 (fi) * | 1999-02-23 | 1999-02-23 | Arctic Partners Oy Ab | Uusi diagnostinen menetelmä |
US8663600B2 (en) | 2005-02-17 | 2014-03-04 | Diaprost Ab | Diagnosis of prostate cancer |
FR2906537A1 (fr) * | 2006-09-28 | 2008-04-04 | Biomerieux Sa | Procede de diagnostic in vitro du cancer broncho-pulmonaire par detection des transcrits majoritaires alternatifs du gene klk8 codant la kallicreine 8 et son utilisation pour le pronostic de survie |
ES2601459T3 (es) | 2011-10-28 | 2017-02-15 | Fredax Ab | Agentes terapéuticos y usos de los mismos |
WO2015075445A1 (fr) | 2013-11-19 | 2015-05-28 | Fredax Ab | Anticorps anti-kallikréine-2 humanisé |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08502889A (ja) * | 1992-10-29 | 1996-04-02 | トーマス・ジェファーソン・ユニバーシティ | 前立腺癌の微小転移を検出する方法 |
CA2187775A1 (fr) * | 1994-04-15 | 1995-10-26 | Aaron E. Katz | Procede de d'evaluation au niveau moleculaire des stades d'evolution du cancer de la prostate |
AU699748B2 (en) * | 1994-05-10 | 1998-12-10 | Hybritech Incorporated | Recombinant HK2 polypeptide |
AU4897896A (en) * | 1995-01-04 | 1996-07-24 | Trustees Of Boston University | Primers for the pcr amplification of metastatic sequences |
CA2212846A1 (fr) * | 1995-02-24 | 1996-08-29 | Sloan-Kettering Institute For Cancer Research | Antigene membranaire specifique de la prostate et ses utilisations |
-
1997
- 1997-11-14 JP JP52288898A patent/JP2001503991A/ja active Pending
- 1997-11-14 CA CA002271770A patent/CA2271770A1/fr not_active Abandoned
- 1997-11-14 CN CN 97199740 patent/CN1238013A/zh active Pending
- 1997-11-14 WO PCT/US1997/020948 patent/WO1998021365A2/fr not_active Application Discontinuation
- 1997-11-14 AU AU52602/98A patent/AU737659B2/en not_active Ceased
- 1997-11-14 EP EP97947550A patent/EP0941368A2/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CN1238013A (zh) | 1999-12-08 |
WO1998021365A3 (fr) | 1998-10-15 |
EP0941368A2 (fr) | 1999-09-15 |
JP2001503991A (ja) | 2001-03-27 |
AU5260298A (en) | 1998-06-03 |
AU737659B2 (en) | 2001-08-23 |
WO1998021365A2 (fr) | 1998-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6479263B1 (en) | Method for detection of micrometastatic prostate cancer | |
JP4205738B2 (ja) | 安定hk2ポリペプチド変異体 | |
EP0948630B1 (fr) | Clonage et caracterisation de napsine, une protease aspartique | |
WO1995030758A9 (fr) | Polypeptide hk2 recombine | |
EP0804593A1 (fr) | Polypeptide hk2 recombine | |
US6482599B1 (en) | Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such | |
WO1998059073A1 (fr) | Procede de detection du cancer du sein | |
AU739546B2 (en) | Forms of prostate specific antigen and methods for their detection | |
AU737659B2 (en) | Method for detection of metastatic prostate cancer | |
EP0974057B1 (fr) | Procede de detection de polypeptides hk2 | |
WO1998002748A9 (fr) | Procede de detection de polypeptides hk2 | |
EP1392719B1 (fr) | Formes d'antigenes specifiques de la prostate et procedes de detection de ceux-ci | |
JP2002538818A (ja) | 前立腺腫瘍組織におけるヒトカリクレイン2とプロテアーゼインヒビター−6の新規な複合体および該複合体の利用方法 | |
US20040259113A1 (en) | Method for detection of metastatic prostate cancer | |
MXPA99004504A (en) | Method for detection of metastatic prostate cancer | |
MXPA99000659A (es) | Metodos para detectar polipeptidos de hk2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |